← Open Payments lookup

KIAM HONG PICADO: Open Payments

NPI 1851172126 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$984 in 36 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $497 · 2025 $984

Food & beverage: $984
CompanyPaymentsAmount
United Therapeutics Corporation6$235
Actelion Pharmaceuticals US, Inc.7$140
Astellas Pharma US Inc2$137
GlaxoSmithKline, LLC.4$101
Takeda Pharmaceuticals U.S.A., Inc.2$63
Grifols USA, LLC3$61
Boehringer Ingelheim Pharmaceuticals, Inc.2$53
ANI Pharmaceuticals, Inc.2$39
AstraZeneca Pharmaceuticals LP2$39
Baxter Healthcare2$38

Products named: Tyvaso, Cresemba, NUCALA, OPSUMIT, ARALAST, Prolastin-C Liquid, JASCAYD, PURIFIED CORTROPHIN GEL.

Industry payments across TX — which companies pay providers there.